|
1
|
Sanli O, Dobruch J, Knowles MA, Burger M,
Alemozaffar M, Nielsen ME and Lotan Y: Bladder cancer. Nat Rev Dis
Primers. 3:170222017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Babjuk M, Böhle A, Burger M, Capoun O,
Cohen D, Compérat EM, Hernández V, Kaasinen E, Palou J, Rouprêt M,
et al: EAU guidelines on non-muscle-invasive urothelial carcinoma
of the bladder: Update 2016. Eur Urol. 71:447–461. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Robertson AG, Kim J, Al-Ahmadie H,
Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA,
Akbani R, et al: Comprehensive molecular characterization of
muscle-invasive bladder cancer. Cell. 171:540–556.e25. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sjödahl G, Lauss M, Lövgren K, Chebil G,
Gudjonsson S, Veerla S, Patschan O, Aine M, Fernö M, Ringnér M, et
al: A molecular taxonomy for urothelial carcinoma. Clin Cancer Res.
18:3377–3386. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Choi W, Porten S, Kim S, Willis D, Plimack
ER, Hoffman-Censits J, Roth B, Cheng T, Tran M, Lee IL, et al:
Identification of distinct basal and luminal subtypes of
muscle-invasive bladder cancer with different sensitivities to
frontline chemotherapy. Cancer Cell. 25:152–165. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang H, Ye YL, Li MX, Ye SB, Huang WR,
Cai TT, He J, Peng JY, Duan TH, Cui J, et al: CXCL2/MIF-CXCR2
signaling promotes the recruitment of myeloid-derived suppressor
cells and is correlated with prognosis in bladder cancer. Oncogene.
36:2095–2104. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kitamura T, Qian BZ and Pollard JW: Immune
cell promotion of metastasis. Nat Rev Immunol. 15:73–86. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Şenbabaoğlu Y, Gejman RS, Winer AG, Liu M,
Van Allen EM, de Velasco G, Miao D, Ostrovnaya I, Drill E, Luna A,
et al: Tumor immune microenvironment characterization in clear cell
renal cell carcinoma identifies prognostic and
immunotherapeutically relevant messenger RNA signatures. Genome
Biol. 17:2312016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang N, Liang H and Zen K: Molecular
mechanisms that influence the macrophage m1-m2 polarization
balance. Front Immunol. 5:6142014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qian BZ and Pollard JW: Macrophage
diversity enhances tumor progression and metastasis. Cell.
141:39–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Na YR, Yoon YN, Son DI and Seok SH:
Cyclooxygenase-2 inhibition blocks M2 macrophage differentiation
and suppresses metastasis in murine breast cancer model. PLoS One.
8:e634512013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ruffell B and Coussens LM: Macrophages and
therapeutic resistance in cancer. Cancer Cell. 27:462–472. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Korpal M, Puyang X, Jeremy Wu Z, Seiler R,
Furman C, Oo HZ, Seiler M, Irwin S, Subramanian V, Julie Joshi J,
et al: Evasion of immunosurveillance by genomic alterations of
PPARγ/RXRα in bladder cancer. Nat Commun. 8:1032017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sjödahl G, Lövgren K, Lauss M, Chebil G,
Patschan O, Gudjonsson S, Månsson W, Fernö M, Leandersson K,
Lindgren D, et al: Infiltration of CD3+ and
CD68+ cells in bladder cancer is subtype specific and
affects the outcome of patients with muscle-invasive tumors. Urol
Oncol. 32:791–797. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miyake M, Tatsumi Y, Gotoh D, Ohnishi S,
Owari T, Iida K, Ohnishi K, Hori S, Morizawa Y, Itami Y, et al:
Regulatory T cells and tumor-associated macrophages in the tumor
microenvironment in non-muscle invasive bladder cancer treated with
intravesical Bacille Calmette-Guérin: A long-term follow-up study
of a Japanese Cohort. Int J Mol Sci. 18(pii): E21862017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bindea G, Mlecnik B, Tosolini M,
Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T,
Lafontaine L, Berger A, et al: Spatiotemporal dynamics of
intratumoral immune cells reveal the immune landscape in human
cancer. Immunity. 39:782–795. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sanyal R, Polyak MJ, Zuccolo J, Puri M,
Deng L, Roberts L, Zuba A, Storek J, Luider JM, Sundberg EM, et al:
MS4A4A: A novel cell surface marker for M2 macrophages and plasma
cells. Immunol Cell Biol. 95:611–619. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ambarus CA, Krausz S, van Eijk M, Hamann
J, Radstake TR, Reedquist KA, Tak PP and Baeten DL: Systematic
validation of specific phenotypic markers for in vitro polarized
human macrophages. J Immunol Methods. 375:196–206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lugo-Villarino G, Troegeler A, Balboa L,
Lastrucci C, Duval C, Mercier I, Bénard A, Capilla F, Al Saati T,
Poincloux R, et al: The C-type lectin receptor DC-SIGN has an
anti-inflammatory role in human M(IL-4) macrophages in response to
Mycobacterium tuberculosis. Front Immunol. 9:11232018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Choi JW, Kwon MJ, Kim IH, Kim YM, Lee MK
and Nam TJ: Pyropia yezoensis glycoprotein promotes the M1 to M2
macrophage phenotypic switch via the STAT3 and STAT6 transcription
factors. Int J Mol Med. 38:666–674. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu M, Yang W, Liu S, Hock D, Zhang B, Huo
RY, Tong X and Yan H: LXRα is expressed at higher levels in healthy
people compared to atherosclerosis patients and its over-expression
polarizes macrophages towards an anti-inflammatory MΦ2 phenotype.
Clin Exp Hypertens. 40:213–217. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lo TH, Silveira PA, Fromm PD, Verma ND, Vu
PA, Kupresanin F, Adam R, Kato M, Cogger VC, Clark GJ and Hart DN:
Characterization of the expression and function of the C-type
lectin receptor CD302 in mice and humans reveals a role in
dendritic cell migration. J Immunol. 197:885–898. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bellora F, Castriconi R, Dondero A,
Reggiardo G, Moretta L, Mantovani A, Moretta A and Bottino C: The
interaction of human natural killer cells with either unpolarized
or polarized macrophages results in different functional outcomes.
Proc Natl Acad Sci USA. 107:21659–21664. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ornstein MC, Diaz-Montero CM, Rayman P,
Elson P, Haywood S, Finke JH, Kim JS, Pavicic PG Jr, Lamenza M,
Devonshire S, et al: Myeloid-derived suppressors cells (MDSC)
correlate with clinicopathologic factors and pathologic complete
response (pCR) in patients with urothelial carcinoma (UC)
undergoing cystectomy. Urol Oncol. 36:405–412. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gielen PR, Schulte BM, Kers-Rebel ED,
Verrijp K, Petersen-Baltussen HM, ter Laan M, Wesseling P and Adema
GJ: Increase in both CD14-positive and CD15-positive
myeloid-derived suppressor cell subpopulations in the blood of
patients with glioma but predominance of CD15-positive
myeloid-derived suppressor cells in glioma tissue. J Neuropathol
Exp Neurol. 74:390–400. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Reich M, Liefeld T, Gould J, Lerner J,
Tamayo P and Mesirov JP: GenePattern 2.0. Nat Genet. 38:500–501.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gentles AJ, Newman AM, Liu CL, Bratman SV,
Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, et al: The
prognostic landscape of genes and infiltrating immune cells across
human cancers. Nat Med. 21:938–945. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zeng S, Yu X, Ma C, Song R, Zhang Z, Zi X,
Chen X, Wang Y, Yu Y, Zhao J, et al: Transcriptome sequencing
identifies ANLN as a promising prognostic biomarker in bladder
urothelial carcinoma. Sci Rep. 7:31512017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chai CY, Chen WT, Hung WC, Kang WY, Huang
YC, Su YC and Yang CH: Hypoxia-inducible factor-1alpha expression
correlates with focal macrophage infiltration, angiogenesis and
unfavourable prognosis in urothelial carcinoma. J Clin Pathol.
61:658–664. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular characterization of urothelial bladder
carcinoma. Nature. 507:315–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
An Y, Adams JR, Hollern DP, Zhao A, Chang
SG, Gams MS, Chung PED, He X, Jangra R, Shah JS, et al: Cdh1 and
Pik3ca mutations cooperate to induce immune-related invasive
lobular carcinoma of the breast. Cell Rep. 25:702–714.e6. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hanada T, Nakagawa M, Emoto A, Nomura T,
Nasu N and Nomura Y: Prognostic value of tumor-associated
macrophage count in human bladder cancer. Int J Urol. 7:263–269.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ayari C, LaRue H, Hovington H, Decobert M,
Harel F, Bergeron A, Têtu B, Lacombe L and Fradet Y: Bladder tumor
infiltrating mature dendritic cells and macrophages as predictors
of response to bacillus Calmette-Guérin immunotherapy. Eur Urol.
55:1386–1395. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Takayama H, Nishimura K, Tsujimura A,
Nakai Y, Nakayama M, Aozasa K, Okuyama A and Nonomura N: Increased
infiltration of tumor associated macrophages is associated with
poor prognosis of bladder carcinoma in situ after intravesical
bacillus Calmette-Guerin instillation. J Urol. 181:1894–1900. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tervahartiala M, Taimen P, Mirtti T,
Koskinen I, Ecke T, Jalkanen S and Boström PJ: Immunological tumor
status may predict response to neoadjuvant chemotherapy and outcome
after radical cystectomy in bladder cancer. Sci Rep. 7:126822017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang X, Ni S, Chen Q, Ma L, Jiao Z, Wang C
and Jia G: Bladder cancer cells induce immunosuppression of T cells
by supporting PD-L1 expression in tumour macrophages partially
through interleukin 10. Cell Biol Int. 41:177–186. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu SQ, Xu R, Li XF, Zhao XK and Qian BZ:
Prognostic roles of tumor associated macrophages in bladder cancer:
A system review and meta-analysis. Oncotarget. 9:25294–25303. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Maniecki MB, Etzerodt A, Ulhøi BP,
Steiniche T, Borre M, Dyrskjøt L, Orntoft TF, Moestrup SK and
Møller HJ: Tumor-promoting macrophages induce the expression of the
macrophage-specific receptor CD163 in malignant cells. Int J
Cancer. 131:2320–2331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Aljabery F, Olsson H, Gimm O, Jahnson S
and Shabo I: M2-macrophage infiltration and macrophage traits of
tumor cells in urinary bladder cancer. Urol Oncol.
36:159.e19–159.e26. 2018. View Article : Google Scholar
|
|
41
|
Fu H, Zhu Y, Wang Y, Liu Z, Zhang J, Xie
H, Fu Q, Dai B, Ye D and Xu J: Identification and validation of
stromal immunotype predict survival and benefit from adjuvant
chemotherapy in patients with muscle-invasive bladder cancer. Clin
Cancer Res. 24:3069–3078. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rubio C, Munera-Maravilla E, Lodewijk I,
Suarez-Cabrera C, Karaivanova V, Ruiz-Palomares R, Paramio JM and
Dueñas M: Macrophage polarization as a novel weapon in conditioning
tumor microenvironment for bladder cancer: Can we turn demons into
gods? Clin Transl Oncol. 21:391–403. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pyonteck SM, Akkari L, Schuhmacher AJ,
Bowman RL, Sevenich L, Quail DF, Olson OC, Quick ML, Huse JT,
Teijeiro V, et al: CSF-1R inhibition alters macrophage polarization
and blocks glioma progression. Nat Med. 19:1264–1272. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhu Y, Knolhoff BL, Meyer MA, Nywening TM,
West BL, Luo J, Wang-Gillam A, Goedegebuure SP, Linehan DC and
DeNardo DG: CSF1/CSF1R blockade reprograms tumor-infiltrating
macrophages and improves response to T-cell checkpoint
immunotherapy in pancreatic cancer models. Cancer Res.
74:5057–5069. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sica A and Mantovani A: Macrophage
plasticity and polarization: In vivo veritas. J Clin Invest.
122:787–795. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bronte V and Murray PJ: Understanding
local macrophage phenotypes in disease: Modulating macrophage
function to treat cancer. Nat Med. 21:117–119. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang Q, Hu B, Hu X, Kim H, Squatrito M,
Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, et al: Tumor
evolution of glioma-intrinsic gene expression subtypes associates
with immunological changes in the microenvironment. Cancer Cell.
32:42–56.e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Rutledge WC, Kong J, Gao J, Gutman DA,
Cooper LA, Appin C, Park Y, Scarpace L, Mikkelsen T, Cohen ML, et
al: Tumor-infiltrating lymphocytes in glioblastoma are associated
with specific genomic alterations and related to transcriptional
class. Clin Cancer Res. 19:4951–4960. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lin EY, Nguyen AV, Russell RG and Pollard
JW: Colony-stimulating factor 1 promotes progression of mammary
tumors to malignancy. J Exp Med. 193:727–740. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Qian BZ, Li J, Zhang H, Kitamura T, Zhang
J, Campion LR, Kaiser EA, Snyder LA and Pollard JW: CCL2 recruits
inflammatory monocytes to facilitate breast-tumour metastasis.
Nature. 475:222–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cortez-Retamozo V, Etzrodt M, Newton A,
Ryan R, Pucci F, Sio SW, Kuswanto W, Rauch PJ, Chudnovskiy A,
Iwamoto Y, et al: Angiotensin II drives the production of
tumor-promoting macrophages. Immunity. 38:296–308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ying W, Tseng A, Chang RC, Morin A, Brehm
T, Triff K, Nair V, Zhuang G, Song H, Kanameni S, et al:
MicroRNA-223 is a crucial mediator of PPARγ-regulated alternative
macrophage activation. J Clin Invest. 125:4149–4159. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
He X, Tang R, Sun Y, Wang YG, Zhen KY,
Zhang DM and Pan WQ: MicroR-146 blocks the activation of M1
macrophage by targeting signal transducer and activator of
transcription 1 in hepatic schistosomiasis. EBioMedicine.
13:339–347. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liu Y, Gu Y and Cao X: The exosomes in
tumor immunity. Oncoimmunology. 4:e10274722015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cooks T, Pateras IS, Jenkins LM, Patel KM,
Robles AI, Morris J, Forshew T, Appella E, Gorgoulis VG and Harris
CC: Mutant p53 cancers reprogram macrophages to tumor supporting
macrophages via exosomal miR-1246. Nat Commun. 9:7712018.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Junker K, Heinzelmann J, Beckham C, Ochiya
T and Jenster G: Extracellular vesicles and their role in urologic
malignancies. Eur Urol. 70:323–331. 2016. View Article : Google Scholar : PubMed/NCBI
|
